Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Farmers Insurance
Citi
Merck
Medtronic
McKinsey
McKesson
Cerilliant
Daiichi Sankyo

Generated: January 21, 2018

DrugPatentWatch Database Preview

Cyproheptadine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cyproheptadine hydrochloride and what is the scope of cyproheptadine hydrochloride patent protection?

Cyproheptadine hydrochloride
is the generic ingredient in two branded drugs marketed by Actavis Mid Atlantic, Bio-pharm Inc, Halsey, Lyne, Morton Grove, Naska, Pharm Assoc, Silarx Pharms Inc, Merck, Ailex Pharms Llc, Am Therap, Apex Pharms Inc, Appco Pharma Llc, Ascot, Chartwell Rx, Duramed Pharms Barr, Impax Labs Inc, Ingenus Pharms Nj, Ivax Sub Teva Pharms, Kv Pharm, Md Pharm, Mylan, Par Pharm, Pioneer Pharms, Pliva, Sandoz, Santos Biotech, Superpharm, Vitarine, Watson Labs, and Zydus Pharms Usa Inc, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for cyproheptadine hydrochloride. Twenty-four suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for cyproheptadine hydrochloride

US Patents and Regulatory Information for cyproheptadine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ingenus Pharms Nj CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 205087-001 Sep 23, 2015 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Santos Biotech CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 040644-001 May 30, 2006 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apex Pharms Inc CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 207783-001 Dec 29, 2016 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Md Pharm CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 087566-001 Nov 10, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck PERIACTIN cyproheptadine hydrochloride SYRUP;ORAL 013220-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Superpharm CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 087405-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Mid Atlantic CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride SYRUP;ORAL 086833-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Halsey CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 089057-001 Jul 3, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ascot CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 087685-001 Oct 25, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 087056-001 Approved Prior to Jan 1, 1982 AA RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Chubb
AstraZeneca
Fish and Richardson
Queensland Health
Federal Trade Commission
Colorcon
Accenture
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot